Primus Pharmaceuticals: Primus Pharmaceuticals Withdraws Limbrel Capsules From The Market

NewsThe voluntary but reluctant move follows a strong recommendation from the Food and Drug Administration that the osteoarthritis product may cause drug-induced liver injury and a lung condition called hypersensitivity pneumonitis. Staff Author: Mike BottaTopics: Recalls